Fosun Pharmaceuticals announced that the company repurchased 264,000 H shares on the Hong Kong Stock Exchange on September 1, 2026. The repurchase price range for each share was HK$16.07 to HK$16.28, with a total repurchase amount of HK$4.278,400. The purchased shares are to be held as treasury shares. This repurchase accounted for 0.05% of the shares issued before the incident. After the repurchase, the issued shares were 540 million shares, and the treasury shares were 115.05 million shares. The repurchase is based on the repurchase authorization passed by the shareholders' meeting on June 16, 2026. The total number of shares that can be repurchased under this authorization is 540.9972 million shares. Up to now, 551,500 shares have been repurchased, accounting for 0.1% of the authorized corresponding shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.